Skip to content

ZenFlex WireWellness, health and fitness releases

Latest Health & Medical Biotech & Pharma Retail & Consumer Weekly Submit a release

Company newsroom

Lipocine Inc.

NASDAQ:LPCN

1 releases

Lipocine Inc.·Nov 10, 2026

Lipocine Doses First Participant in BLOOM Phase 3 Study of LPCN 1154 for Postpartum Depression

ZenFlex Wire

Press releases on this site are supplied by the issuing organizations and their distribution partners. ZenFlex Wire does not write or endorse them. Paid releases are labeled Sponsored.

About Editorial policy Corrections & removals Disclaimer Contact Submit a release Archive Sources RSS

Part of the PR Direct network:Insights Emerge Major Health News Elle Digest Today Parents GiftCart Online

© 2026 ZenFlex Wire